Cargando…

Hypertrophic obstructive cardiomyopathy complicated with acute myocardial infarction and diffuse fibrosis: surgery or not?

BACKGROUND: Hypertrophic cardiomyopathy with extreme hypertrophy, biventricular obstruction and diffuse myocardial fibrosis complicated by myocardial infarction in the absence of obstructive coronary artery disease (MINOCA) is a rare phenotype. Evidence and guideline recommendations are still lackin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yunhong, Zhao, Xuemei, Zhai, Mei, Huang, Yan, Zhou, Qiong, Zhang, Yuhui, Mao, Yi, Zhang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008966/ https://www.ncbi.nlm.nih.gov/pubmed/35418024 http://dx.doi.org/10.1186/s12872-022-02602-z

Ejemplares similares

Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
por: Hussain, Tarique, et al.
Publicado: (2013)

Myocardial fibrosis in desmin-related hypertrophic cardiomyopathy
por: He, Yi, et al.
Publicado: (2010)

In vivo diffusion-weighted MRI detection of myocardial fibrosis in hypertrophic cardiomyopathy patients
por: Nguyen, Christopher T, et al.
Publicado: (2015)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Sex differences in atrial remodeling and its relationship with myocardial fibrosis in hypertrophic obstructive cardiomyopathy
por: Bi, Xuanye, et al.
Publicado: (2022)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy
por: Brouwer, Wessel P, et al.
Publicado: (2014)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: What Remains to be Proven?
por: Sara, Leonardo
Publicado: (2019)

MicroRNA-221 is a potential biomarker of myocardial hypertrophy and fibrosis in hypertrophic obstructive cardiomyopathy
por: Huang, Derong, et al.
Publicado: (2020)

Hypertrophic Obstructive Cardiomyopathy
por: Cohen, Lawrence S.
Publicado: (1972)

Contrast-free detection of myocardial fibrosis in hypertrophic cardiomyopathy patients with diffusion-weighted cardiovascular magnetic resonance
por: Nguyen, Christopher, et al.
Publicado: (2015)

Indications for Surgery in Obstructive Hypertrophic Cardiomyopathy
por: Sherrid, Mark V.
Publicado: (2020)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
por: Raman, Betty, et al.
Publicado: (2019)

Myocardial Fibrosis in Hypertrophic Cardiomyopathy: A Perspective from Fibroblasts
por: Schlittler, Maja, et al.
Publicado: (2023)

Acute myocardial infarction occurring after hypertrophic obstructive cardiomyopathy with paroxysmal atrial fibrillation: a case report
por: Fang, Dingfeng, et al.
Publicado: (2022)

Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy
por: Kuusisto, Johanna, et al.
Publicado: (2012)

ECHOCARDIOGRAPHY FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: Irpachi, Kalpna, et al.
Publicado: (2017)

Infective endocarditis due to Gemella morbillorum complicating hypertrophic obstructive cardiomyopathy.
por: Kerr, J. R., et al.
Publicado: (1994)

Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction
por: Ellims, Andris H, et al.
Publicado: (2012)

The value of myocardial work in assessment of ventricular function in patients with non-obstructive hypertrophic cardiomyopathy
por: Yang, Chenguang, et al.
Publicado: (2022)

Scar heterogeneity in hypertrophic cardiomyopathy. Comparison with chronic myocardial infarction and normal subjects
por: Vianello, Pier Filippo, et al.
Publicado: (2014)

Predictive Values of N-Terminal Pro-B-Type Natriuretic Peptide and Cardiac Troponin I for Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy
por: Zhang, Changlin, et al.
Publicado: (2016)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Examining the impact of inducible ischemia on myocardial fibrosis and exercise capacity in hypertrophic cardiomyopathy
por: Malahfji, Maan, et al.
Publicado: (2020)

Genotype-Related Clinical Characteristics and Myocardial Fibrosis and Their Association with Prognosis in Hypertrophic Cardiomyopathy
por: Kim, Hyung Yoon, et al.
Publicado: (2020)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Chung, Hyemoon, et al.
Publicado: (2021)

Rare exacerbation of myocardial bridge after septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a case report
por: Wu, Zhenguo, et al.
Publicado: (2023)

Exercise and myocardial injury in hypertrophic cardiomyopathy
por: Cramer, G Etienne, et al.
Publicado: (2020)

Interrelationship of LV mass, focal fibrosis by LGE, and diffuse fibrosis by T1-changes in patients with hypertrophic cardiomyopathy
por: Potluri, Rahul, et al.
Publicado: (2012)

Exacerbation of left ventricular outlet obstruction in hypertrophic obstructive cardiomyopathy: an unexpected complication of gastric banding
por: Mahamid, Ahmad, et al.
Publicado: (2014)

Infective Endocarditis Complicating Hypertrophic Obstructive Cardiomyopathy: Is Antibiotic Prophylaxis Really Unnecessary?
por: Guler, Ahmet, et al.
Publicado: (2013)

Regional diffuse fibrosis and strain characteristics differ between children with hypertrophic and dilated cardiomyopathy
por: Patel, Jyoti K, et al.
Publicado: (2015)

Hypertrophic Cardiomyopathy Mimicking Acute Anterior Myocardial Infarction Associated with Sudden Cardiac Death
por: Daralammouri, Y., et al.
Publicado: (2012)

Evaluation of diastolic dysfunction in children with hypertrophic cardiomyopathy and its relationship with development of myocardial fibrosis
por: Deraz, Salem Elsayed, et al.
Publicado: (2023)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
por: Feng, Jiayu, et al.
Publicado: (2022)

Managing Myocardial Bridge and Right Ventricular Outflow Tract Obstruction in an Adolescent With Hypertrophic Cardiomyopathy
por: Joseph, Alysha, et al.
Publicado: (2023)

Bilateral Renal Infarction Secondary to Hypertrophic Cardiomyopathy
por: Farooqi, Rehan, et al.
Publicado: (2019)

Diffuse Myocardial Fibrosis detected by Multi-slice T(1) Mapping using Slice Interleaved T(1) (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2016)

Stress cardiomyopathy in a patient with hypertrophic cardiomyopathy and myocardial bridging
por: Benavides, Miguel, et al.
Publicado: (2017)

The consolidation of surgery for hypertrophic obstructive cardiomyopathy in Asia and the Pacific Rim
por: Quintana, Eduard, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt7c8mjvdpvl2vg24knl0buikk